Related Experiment Video

Updated: Jul 6, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Photophobia and methylphenidate

Ahmad Ghanizadeh1, Kamran Aghakhani

  • 1Shiraz University of Medical Sciences, Hafez Hospital, Shiraz, Iran. ghanizad@sina.tums.ac.ir

Psychopharmacology Bulletin
|March 26, 2008
PubMed

Insights

Photophobia, or light sensitivity, may be an adverse effect of methylphenidate (MPH) in children with attention-deficit hyperactivity disorder (ADHD). This sensitivity can reappear immediately upon MPH reintroduction, potentially impacting mood and behavior.

Area of Science:

  • Neuroscience
  • Pediatric Psychiatry
  • Ophthalmology

Background:

  • Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
  • Methylphenidate (MPH) is a frequently prescribed stimulant medication for managing ADHD symptoms.
  • Understanding potential adverse effects of MPH is crucial for optimizing treatment outcomes.

Observation:

  • A case report details a 7-year-old boy diagnosed with ADHD experiencing bilateral photophobia.
  • The photophobia consistently reappeared upon methylphenidate (MPH) administration and resolved upon discontinuation.
  • This reaction was reproducible across multiple trials of MPH initiation and cessation.

Findings:

  • Photophobia emerged as a potential adverse effect associated with methylphenidate (MPH) treatment in this pediatric ADHD case.
  • The immediate recurrence of photophobia upon MPH reintroduction suggests a direct causal link.
  • The study posits that MPH-induced cortical excitability may heighten sensitivity to light.

Implications:

  • Photophobia should be considered as a possible side effect in ADHD children treated with MPH.
  • Increased light sensitivity could contribute to irritability and sadness in affected children.
  • Further investigation into MPH's ocular side effects is warranted to improve patient care and medication management.

More Related Videos

Electrophysiological Methods for Measuring Photopigment Levels in Drosophila Photoreceptors08:09

Electrophysiological Methods for Measuring Photopigment Levels in Drosophila Photoreceptors

Published on: June 2, 2022

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...